BPC-157

Description

BPC-157

BPC-157, or Body Protection Compound-157, is a regenerative peptide originally isolated from a protective protein in the stomach lining. It has gained significant attention in wellness and performance studies due to its potential role in accelerating recovery, repairing tissues, supporting gut health, healing tendons, and modulating inflammation. Frequently utilized to aid in the recovery of muscles, ligaments, tendons, joints, and the digestive system, it is also believed to encourage angiogenesis and enhance cellular repair mechanisms.

Also known as: Body Protection Compound-157, Pentadecapeptide BPC 157

•Status: Currently in preclinical stage, classified by the FDA as Category 2. A reclassification to Category 1 has been proposed following the HHS announcement of April 15, 2026, but this change has not yet taken effect under existing regulations. The formal FDA decision is pending, with a scheduled PCAC review on July 23–24, 2026, and official publication to follow. Evidence is based on animal studies.
•Typical dosage: 250–500 mcg administered once or twice daily. Delivery methods include subcutaneous injection near the site of injury or systemic administration.
•Studied for potential use in recovery from injuries, healing of gastrointestinal tissue, and repair of joints and tendons.